| Gene set | Source | Modules |
| 26S proteasome | GO | 28 91 |
| 3'\,5'-cyclic-nucleotide phosphodiesterase activity | Tissue | 560 |
| A2058_1 | Tissue | 18 52 118 |
| A2058_2 | Tissue | 18 52 118 |
| acetylcholine receptor activity | GO | 216 267 328 415 |
| acid-D-amino acid ligase activity | GO | 233 278 |
| actin binding | GO | 419 524 |
| actin filament-based movement | GO | 330 387 512 |
| actin filament-based process | GO | 330 387 512 |
| acyl-CoA dehydrogenase activity | GO | 184 221 |
| adenylate cyclase activation | GO | 454 575 |
| Adrenal_gland_1 | Tissue | 19 |
| Adrenal_gland_2 | Tissue | 19 |
| alcohol dehydrogenase activity | GO | 514 |
| alcohol dehydrogenase activity\, zinc-dependent | Tissue | 514 |
| aldehyde dehydrogenase activity | GO | 464 |
| aldehyde metabolism | GO | 519 |
| Alizadeh00 11 | Clusters | 238 301 361 436 |
| Alizadeh00 13 | Clusters | 237 301 361 436 |
| Alizadeh00 16 | Clusters | 97 182 261 358 525 |
| Alizadeh00 18 | Clusters | 145 188 238 301 361 436 |
| Alizadeh00 19 | Clusters | 169 |
| Alizadeh00 20 | Clusters | 54 |
| Alizadeh00 21 | Clusters | 495 |
| Alizadeh00 23 | Clusters | 255 317 378 459 532 |
| Alizadeh00 25 | Clusters | 79 128 170 |
| Alizadeh00 27 | Clusters | 301 361 436 |
| Alizadeh00 29 | Clusters | 128 170 |
| Alizadeh00 30 | Clusters | 317 378 459 532 |
| Alizadeh00 31 | Clusters | 429 484 |
| Alizadeh00 33 | Clusters | 69 136 179 255 317 378 459 532 |
| Alizadeh00 34 | Clusters | 378 459 532 |
| Alizadeh00 36 | Clusters | 208 292 345 436 |
| Alizadeh00 3 | Clusters | 136 179 255 317 378 459 532 |
| Alizadeh00 40 | Clusters | 37 69 136 179 255 317 378 459 532 |
| Alizadeh00 42 | Clusters | 61 126 |
| Alizadeh00 43 | Clusters | 261 358 525 |
| Alizadeh00 44 | Clusters | 534 |
| Alizadeh00 45 | Clusters | 430 484 |
| Alizadeh00 46 | Clusters | 456 |
| Alizadeh00 48 | Clusters | 436 |
| Alizadeh00 4 | Clusters | 179 255 317 378 459 532 |
| Alizadeh00 5 | Clusters | 292 345 436 |
| Alizadeh00 6 | Clusters | 277 358 525 |
| Alizadeh00 8 | Clusters | 361 436 |
| Alizadeh00 9 | Clusters | 182 261 358 525 |
| alpha-type channel activity | GO | 316 415 |
| amine metabolism | GO | 78 |
| amine oxidase activity | GO | 557 |
| amine receptor activity | GO | 383 441 |
| amino acid activation | GO | 110 160 |
| amino acid and derivative metabolism | GO | 78 |
| amino acid biosynthesis | GO | 354 |
| amino acid metabolism | GO | 235 |
| Aminoacyl-tRNA_biosynthesis | KEGG | 133 160 |
| Amygdala_1 | Tissue | 11 66 100 137 |
| Amygdala_2 | Tissue | 11 66 100 137 |
| Androgen_and_estrogen_metabolism | KEGG | 505 |
| angiogenesis | GO | 178 362 444 516 |
| anion transport | GO | 141 396 489 |
| anti-apoptosis | GO | 537 |
| antibacterial peptide activity | GO | 423 478 |
| anticoagulant activity | GO | 328 415 |
| antifungal peptide activity | GO | 423 478 |
| antigen binding | GO | 522 |
| antigen presentation\, endogenous antigen | Tissue | 144 293 345 436 |
| antigen presentation\, peptide antigen | Tissue | 143 293 345 436 |
| antigen processing\, endogenous antigen via MHC class I | Tissue | 144 293 345 436 |
| antigen processing\, exogenous antigen via MHC class II | Tissue | 543 |
| antigen processing | GO | 143 293 345 436 |
| antimicrobial peptide activity | GO | 247 |
| apoptosis inhibitor activity | GO | 537 |
| apoptotic program | GO | 528 |
| Apotosis | KEGG | 340 |
| Armstrong01 11 | Clusters | 104 181 242 379 |
| Armstrong01 12 | Clusters | 13 41 104 181 242 379 |
| Armstrong01 13 | Clusters | 94 |
| Armstrong01 21 | Clusters | 104 181 242 379 |
| Armstrong01 22 | Clusters | 99 129 |
| Armstrong01 25 | Clusters | 545 |
| Armstrong01 26 | Clusters | 181 242 379 |
| Armstrong01 27 | Clusters | 83 114 151 |
| Armstrong01 29 | Clusters | 441 |
| Armstrong01 31 | Clusters | 54 |
| Armstrong01 32 | Clusters | 83 114 151 |
| Armstrong01 34 | Clusters | 204 |
| Armstrong01 37 | Clusters | 99 129 |
| Armstrong01 38 | Clusters | 204 |
| Armstrong01 39 | Clusters | 59 |
| Armstrong01 40 | Clusters | 204 |
| Armstrong01 42 | Clusters | 129 |
| Armstrong01 44 | Clusters | 204 |
| Armstrong01 47 | Clusters | 533 |
| Armstrong01 48 | Clusters | 104 181 242 379 |
| Armstrong01 4 | Clusters | 41 104 181 242 379 |
| Armstrong01 5 | Clusters | 99 129 |
| Armstrong01 6 | Clusters | 99 129 |
| aromatic amino acid family metabolism | GO | 140 |
| ATPase activity\, coupled | Tissue | 229 318 403 451 |
| ATP binding | GO | 244 |
| ATP synthesis coupled electron transport (sensu Eukarya) | GO | 25 77 152 |
| ATP_Synthesis | KEGG | 116 152 |
| Benzoate_degradation | KEGG | 303 403 451 |
| Bhattacharjee01 11 | Clusters | 181 242 379 |
| Bhattacharjee01 15 | Clusters | 448 |
| Bhattacharjee01 16 | Clusters | 99 129 |
| Bhattacharjee01 18 | Clusters | 181 242 379 |
| Bhattacharjee01 19 | Clusters | 94 |
| Bhattacharjee01 20 | Clusters | 83 114 151 |
| Bhattacharjee01 22 | Clusters | 47 |
| Bhattacharjee01 23 | Clusters | 104 181 242 379 |
| Bhattacharjee01 24 | Clusters | 99 129 |
| Bhattacharjee01 25 | Clusters | 104 181 242 379 |
| Bhattacharjee01 38 | Clusters | 489 |
| Bhattacharjee01 6 | Clusters | 99 129 |
| Bhattacharjee01 7 | Clusters | 84 |
| biogenic amine metabolism | GO | 440 |
| Blader01 12 | Clusters | 323 |
| Blader01 24 | Clusters | 495 |
| Blader01 28 | Clusters | 495 |
| Blader01 36 | Clusters | 495 |
| Blader01 37 | Clusters | 495 |
| Blader01 38 | Clusters | 495 |
| Blader01 40 | Clusters | 458 |
| Blader01 50 | Clusters | 151 |
| blood coagulation | GO | 131 |
| blood group antigen | GO | 539 |
| Boldrick02 10 | Clusters | 119 171 208 292 345 436 |
| Boldrick02 11 | Clusters | 358 525 |
| Boldrick02 12 | Clusters | 126 |
| Boldrick02 15 | Clusters | 37 69 136 179 255 317 378 459 532 |
| Boldrick02 16 | Clusters | 126 |
| Boldrick02 17 | Clusters | 179 255 317 378 459 532 |
| Boldrick02 18 | Clusters | 171 208 292 345 436 |
| Boldrick02 19 | Clusters | 481 544 |
| Boldrick02 20 | Clusters | 69 136 179 255 317 378 459 532 |
| Boldrick02 22 | Clusters | 308 |
| Boldrick02 26 | Clusters | 481 544 |
| Boldrick02 27 | Clusters | 136 179 255 317 378 459 532 |
| Boldrick02 28 | Clusters | 126 |
| Boldrick02 30 | Clusters | 522 |
| Boldrick02 32 | Clusters | 308 |
| Boldrick02 34 | Clusters | 229 318 403 451 |
| Boldrick02 35 | Clusters | 532 |
| Boldrick02 36 | Clusters | 119 171 208 292 345 436 |
| Boldrick02 40 | Clusters | 465 560 |
| Boldrick02 46 | Clusters | 317 378 459 532 |
| Boldrick02 49 | Clusters | 261 358 525 |
| Boldrick02 4 | Clusters | 171 208 292 345 436 |
| Boldrick02 5 | Clusters | 372 441 |
| Boldrick02 8 | Clusters | 255 317 378 459 532 |
| Boldrick02 9 | Clusters | 119 171 208 292 345 436 |
| bone remodeling | GO | 234 |
| brain development | GO | 372 441 |
| Burkitts_Daudi_1 | Tissue | 53 118 |
| Burkitts_Daudi_2 | Tissue | 53 118 |
| Burkitts_Raji_1 | Tissue | 53 118 |
| Burkitts_Raji_2 | Tissue | 53 118 |
| calcium-dependent phospholipid binding | GO | 390 543 |
| calcium ion binding | GO | 324 |
| calcium ion homeostasis | GO | 262 |
| carbohydrate binding | GO | 96 410 |
| carbohydrate metabolism | GO | 212 |
| carbohydrate transporter activity | GO | 311 573 |
| carbon-carbon lyase activity | GO | 272 377 |
| Carbon_fixation | KEGG | 377 |
| carbon-oxygen lyase activity | GO | 295 343 |
| carboxylic acid biosynthesis | GO | 327 462 |
| carboxylic acid catabolism | GO | 417 |
| carboxylic acid metabolism | GO | 40 |
| carboxylic acid transporter activity | GO | 71 186 341 411 511 |
| carboxylic acid transport | GO | 71 186 341 411 511 |
| carboxylic ester hydrolase activity | GO | 401 |
| carboxypeptidase A activity | GO | 231 402 492 568 |
| carboxypeptidase activity | GO | 402 492 568 |
| catabolism | GO | 172 209 |
| catalytic activity | GO | 212 |
| cation homeostasis | GO | 191 262 |
| cation transporter activity | GO | 307 |
| cation transport | GO | 498 |
| Caudate_nucleus_1 | Tissue | 11 66 100 137 |
| Caudate_nucleus_2 | Tissue | 11 66 100 137 |
| cbb3-type cytochrome c oxidase | GO | 103 152 |
| cell adhesion | GO | 122 |
| cell adhesion molecule activity | GO | 122 |
| cell adhesion receptor activity | GO | 275 412 |
| cell-cell signaling | GO | 92 |
| cell cycle checkpoint | GO | 372 441 |
| Cell cycle | GenMapp | 57 |
| Cell_cycle | KEGG | 57 |
| cell death | GO | 399 |
| cell ion homeostasis | GO | 191 262 |
| cell-matrix adhesion | GO | 412 |
| cell migration | GO | 411 511 |
| cellular morphogenesis | GO | 524 |
| central nervous system development | GO | 497 |
| Cerebellum_1 | Tissue | 11 66 100 137 |
| Cerebellum_2 | Tissue | 11 66 100 137 |
| cGMP biosynthesis | GO | 445 516 |
| channel/pore class transporter activity | GO | 63 |
| chaperone activity | GO | 299 355 |
| chemokine receptor binding | GO | 263 |
| chemosensory perception | GO | 123 197 252 |
| chemotaxis | GO | 108 263 |
| Chen02 11 | Clusters | 458 |
| Chen02 13 | Clusters | 205 |
| Chen02 14 | Clusters | 67 |
| Chen02 19 | Clusters | 239 |
| Chen02 1 | Clusters | 257 |
| Chen02 27 | Clusters | 451 |
| Chen02 2 | Clusters | 493 |
| Chen02 33 | Clusters | 49 95 163 |
| Chen02 47 | Clusters | 212 |
| Chen02 50 | Clusters | 84 |
| Chen02 6 | Clusters | 239 |
| Chen02 8 | Clusters | 48 95 163 |
| chloride transport | GO | 396 489 |
| Cholesterol Biosynthesis | GenMapp | 432 |
| cholesterol biosynthesis | GO | 432 |
| cholesterol metabolism | GO | 236 |
| chromatin assembly/disassembly | GO | 189 552 |
| chromatin | GO | 552 |
| chromatin remodeling complex | GO | 450 538 |
| chromosome | GO | 168 222 421 534 |
| chromosome organization and biogenesis (sensu Eukarya) | GO | 392 457 |
| chymotrypsin activity | GO | 109 |
| Citrate_cycle_TCA_cycle | KEGG | 306 |
| clathrin vesicle coat | GO | 264 395 509 |
| coated vesicle | GO | 39 264 395 509 |
| collagen binding | GO | 513 |
| collagen catabolism | GO | 211 562 |
| complement activation\, classical pathway | Tissue | 58 130 |
| Complement Activation, Classical Pathway | GenMapp | 130 |
| complement activation | GO | 58 130 |
| complement activity | GO | 130 |
| compound eye morphogenesis (sensu Drosophila) | GO | 80 200 259 |
| condensed chromosome | GO | 222 421 534 |
| condensed nuclear chromosome kinetochore | GO | 421 534 |
| conjugation with cellular fusion | GO | 573 |
| conjugation without cellular fusion | GO | 289 375 |
| Corpus_callosum_1 | Tissue | 11 66 100 137 |
| Corpus_callosum_2 | Tissue | 11 66 100 137 |
| Corpus_callosum_3 | Tissue | 11 66 100 137 |
| Cortex | Tissue | 11 66 100 137 |
| Cuadras02 22 | Clusters | 350 |
| Cuadras02 33 | Clusters | 363 |
| Cuadras02 35 | Clusters | 95 163 |
| Cuadras02 48 | Clusters | 372 441 |
| Cuadras02 9 | Clusters | 243 |
| cyclic nucleotide biosynthesis | GO | 65 445 516 |
| cyclic nucleotide metabolism | GO | 65 445 516 |
| cysteine metabolism | GO | 428 471 528 |
| Cysteine_metabolism | KEGG | 530 |
| cytochrome c oxidase activity | GO | 103 152 |
| cytochrome P450 activity | GO | 106 135 |
| cytokine activity | GO | 433 |
| cytolysis | GO | 575 |
| Cytoplasmic Ribosomal Proteins | GenMapp | 83 114 151 |
| Cytoplasmic tRNA Synthetases | GenMapp | 133 160 |
| cytoskeletal protein binding | GO | 419 524 |
| cytoskeleton-dependent intracellular transport | GO | 196 253 |
| cytosolic calcium ion concentration elevation | GO | 288 375 |
| cytosolic large ribosomal subunit (sensu Eukarya) | GO | 83 114 151 |
| cytosolic small ribosomal subunit (sensu Eukarya) | GO | 29 83 114 151 |
| damaged DNA binding | GO | 392 457 |
| defense response | GO | 223 |
| Detweiler01 13 | Clusters | 95 163 |
| Detweiler01 19 | Clusters | 372 441 |
| Detweiler01 20 | Clusters | 257 |
| Detweiler01 23 | Clusters | 9 48 95 163 |
| Detweiler01 24 | Clusters | 383 441 |
| Detweiler01 27 | Clusters | 342 |
| Detweiler01 29 | Clusters | 239 |
| Detweiler01 36 | Clusters | 397 |
| Detweiler01 41 | Clusters | 205 |
| Detweiler01 49 | Clusters | 486 |
| Detweiler01 8 | Clusters | 114 151 |
| development | GO | 220 |
| DNA binding | GO | 198 252 |
| DNA dependent ATPase activity | GO | 318 403 451 |
| DNA dependent DNA replication | GO | 125 158 |
| DNA packaging | GO | 127 189 552 |
| DNA replication and chromosome cycle | GO | 125 158 |
| DNA replication | GO | 125 158 |
| DOHH2_1 | Tissue | 53 118 |
| DOHH2_2 | Tissue | 53 118 |
| DRG_1 | Tissue | 2 |
| DRG_2 | Tissue | 2 |
| ectoderm development | GO | 153 297 357 |
| eicosanoid biosynthesis | GO | 148 326 462 |
| eicosanoid metabolism | GO | 148 326 462 |
| Eicosanoid Synthesis | GenMapp | 431 |
| Electron Transport Chain | GenMapp | 62 152 |
| electron transporter activity | GO | 93 |
| electron transport | GO | 43 |
| embryonic development | GO | 14 178 362 444 516 |
| embryonic pattern specification | GO | 14 178 362 444 516 |
| endomembrane system | GO | 98 198 252 |
| endonuclease activity | GO | 360 439 |
| endopeptidase activity | GO | 209 |
| endopeptidase inhibitor activity | GO | 164 |
| endoribonuclease activity | GO | 467 |
| energy derivation by oxidation of organic compounds | GO | 306 |
| energy pathways | GO | 43 |
| energy taxis | GO | 108 263 |
| enzyme inhibitor activity | GO | 164 |
| ephrin receptor activity | GO | 493 |
| epidermal differentiation | GO | 153 297 357 |
| establishment and/or maintenance of chromatin architecture | GO | 127 189 552 |
| eukaryotic 43S pre-initiation complex | GO | 149 |
| eukaryotic translation initiation factor 3 complex | GO | 447 |
| excitatory extracellular ligand-gated ion channel activity | GO | 267 328 415 |
| excretion | GO | 416 |
| extracellular ligand-gated ion channel activity | GO | 214 |
| extracellular matrix structural constituent | GO | 122 |
| eye photoreceptor cell fate commitment | GO | 80 200 259 |
| fatty acid beta-oxidation | GO | 185 221 |
| fatty acid biosynthesis | GO | 326 462 |
| Fatty Acid Degradation | GenMapp | 184 221 |
| fatty acid oxidation | GO | 185 221 |
| Fc receptor activity | GO | 424 478 |
| Fetal_brain_1 | Tissue | 11 66 100 137 |
| Fetal_brain_2 | Tissue | 11 66 100 137 |
| Fetal_liver_1 | Tissue | 24 55 88 |
| Fetal_liver_2 | Tissue | 24 55 88 |
| fibrillar collagen | GO | 513 |
| GA10_1 | Tissue | 53 118 |
| GA10_2 | Tissue | 53 118 |
| GABA-A receptor activity | GO | 215 |
| galactose binding | GO | 391 543 |
| gap-junction forming channel activity | GO | 482 544 |
| gap junction | GO | 482 544 |
| Garber01 10 | Clusters | 49 95 163 |
| Garber01 19 | Clusters | 67 |
| Garber01 20 | Clusters | 486 |
| Garber01 23 | Clusters | 54 |
| Garber01 28 | Clusters | 441 |
| Garber01 30 | Clusters | 534 |
| Garber01 31 | Clusters | 47 |
| Garber01 35 | Clusters | 312 439 |
| Garber01 43 | Clusters | 83 114 151 |
| Garber01 45 | Clusters | 84 |
| Garber01 48 | Clusters | 372 441 |
| Garber01 49 | Clusters | 95 163 |
| Garber01 4 | Clusters | 154 297 357 |
| Garber01 50 | Clusters | 205 |
| glutathione conjugation reaction | GO | 101 132 310 |
| Glutathione_metabolism | KEGG | 310 |
| glutathione peroxidase activity | GO | 530 |
| glutathione transferase activity | GO | 101 132 310 |
| Glycerolipid_metabolism | KEGG | 557 |
| Glycolysis and Gluconeogenesis | GenMapp | 377 |
| glycolysis | GO | 306 |
| glycosaminoglycan binding | GO | 385 |
| glycosaminoglycan metabolism | GO | 509 |
| Golub99 11 | Clusters | 20 111 157 242 379 |
| Golub99 12 | Clusters | 120 175 241 291 |
| Golub99 15 | Clusters | 105 |
| Golub99 17 | Clusters | 83 114 151 |
| Golub99 18 | Clusters | 111 157 242 379 |
| Golub99 19 | Clusters | 120 175 241 291 |
| Golub99 1 | Clusters | 120 175 241 291 |
| Golub99 23 | Clusters | 112 176 |
| Golub99 24 | Clusters | 175 241 291 |
| Golub99 30 | Clusters | 175 241 291 |
| Golub99 31 | Clusters | 111 157 242 379 |
| Golub99 32 | Clusters | 33 |
| Golub99 41 | Clusters | 120 175 241 291 |
| Golub99 42 | Clusters | 120 175 241 291 |
| Golub99 43 | Clusters | 120 175 241 291 |
| Golub99 44 | Clusters | 157 242 379 |
| Golub99 45 | Clusters | 204 |
| Golub99 46 | Clusters | 400 |
| Golub99 48 | Clusters | 111 157 242 379 |
| Golub99 49 | Clusters | 113 176 |
| Golub99 7 | Clusters | 151 |
| Golub99 8 | Clusters | 501 |
| GPCRs, Class A Rhodopsin-like 2 | GenMapp | 571 |
| GPCRs, Class B Secretin-like | GenMapp | 470 557 |
| GPCRs, Class C Metabotropic glutamate, pheromone | GenMapp | 493 |
| GPI-anchored membrane-bound receptor | GO | 328 415 |
| G-protein chemoattractant receptor activity | GO | 288 375 |
| G-protein coupled receptor activity | GO | 146 |
| G-protein coupled receptor protein signaling pathway | GO | 289 375 |
| G-protein signaling\, adenylate cyclase activating pathway | Tissue | 454 575 |
| G-protein signaling\, coupled to IP3 second messenger (phospholipase C activating) | Tissue | 367 |
| growth factor activity | GO | 433 |
| growth factor binding | GO | 190 474 |
| GTPase activity | GO | 86 |
| GTP binding | GO | 87 |
| guanylate cyclase activity | GO | 445 516 |
| Heart_1 | Tissue | 60 88 |
| Heart_2 | Tissue | 60 88 |
| heat shock protein activity | GO | 355 |
| hematopoietin/interferon-class (D200-domain) cytokine receptor activity | GO | 265 |
| Heme Biosynthesis | GenMapp | 227 539 |
| heme biosynthesis | GO | 335 505 |
| hemostasis | GO | 131 |
| Hep3b_1 | Tissue | 8 52 118 |
| Hep3b_2 | Tissue | 8 52 118 |
| heparin binding | GO | 385 |
| heterocycle metabolism | GO | 376 450 538 |
| heterophilic cell adhesion | GO | 410 |
| hexosaminidase activity | GO | 408 491 568 |
| Histidine_metabolism | KEGG | 373 |
| histogenesis | GO | 153 297 357 |
| HL60_1 | Tissue | 16 53 118 |
| HL60_2 | Tissue | 16 53 118 |
| hormone activity | GO | 382 |
| hormone metabolism | GO | 445 516 |
| host-pathogen interaction | GO | 254 312 439 |
| humoral immune response | GO | 75 |
| HUVEC_1 | Tissue | 52 118 |
| HUVEC_2 | Tissue | 3 52 118 |
| HUVEC_3 | Tissue | 3 52 118 |
| hydrogen-exporting ATPase activity\, phosphorylative mechanism | Tissue | 402 492 568 |
| hydrogen ion transporter activity | GO | 62 152 |
| hydrolase activity | GO | 151 |
| hydrolase activity\, hydrolyzing O-glycosyl compounds | Tissue | 492 568 |
| hydro-lyase activity | GO | 295 343 |
| immune response | GO | 46 75 |
| immunoglobulin receptor activity | GO | 424 478 |
| induction of programmed cell death | GO | 300 399 |
| inflammatory response | GO | 76 |
| inner membrane | GO | 62 152 |
| inorganic anion transport | GO | 141 396 489 |
| inositol/phosphatidylinositol kinase activity | GO | 421 534 |
| inotropic glutamate receptor activity | GO | 498 |
| insulin-like growth factor binding | GO | 190 474 |
| integral to plasma membrane | GO | 64 |
| integrin complex | GO | 275 412 |
| integrin-mediated signaling pathway | GO | 275 412 |
| interleukin-1 receptor activity | GO | 496 545 |
| interleukin-1\, Type I\, activating receptor activity | Tissue | 496 545 |
| interleukin binding | GO | 73 265 |
| interleukin receptor activity | GO | 73 265 |
| intermediate filament | GO | 68 298 357 |
| intracellular transport | GO | 196 253 |
| ion channel activity | GO | 316 415 |
| ion transporter activity | GO | 62 152 |
| ion transport | GO | 316 415 |
| iron ion homeostasis | GO | 540 |
| Iyer99 14 | Clusters | 447 |
| Iyer99 15 | Clusters | 511 |
| Iyer99 17 | Clusters | 54 |
| Iyer99 31 | Clusters | 151 |
| Iyer99 34 | Clusters | 418 455 |
| Iyer99 44 | Clusters | 372 441 |
| Iyer99 4 | Clusters | 418 455 |
| Iyer99 9 | Clusters | 426 |
| K422_1 | Tissue | 53 118 |
| K422_2 | Tissue | 53 118 |
| Kidney_1 | Tissue | 55 88 |
| Kidney_2 | Tissue | 55 88 |
| Kidney_3 | Tissue | 55 88 |
| kinase activity | GO | 160 |
| kinesin complex | GO | 438 533 |
| kinetochore | GO | 315 |
| large ribosomal subunit | GO | 83 114 151 |
| Lessnick02 15 | Clusters | 104 181 242 379 |
| Lessnick02 18 | Clusters | 340 |
| Lessnick02 20 | Clusters | 54 |
| Lessnick02 25 | Clusters | 13 41 104 181 242 379 |
| Lessnick02 26 | Clusters | 181 242 379 |
| Lessnick02 36 | Clusters | 104 181 242 379 |
| Lessnick02 38 | Clusters | 117 |
| Lessnick02 3 | Clusters | 104 181 242 379 |
| Lessnick02 48 | Clusters | 379 |
| Lessnick02 4 | Clusters | 83 114 151 |
| leukotriene biosynthesis | GO | 326 462 |
| ligand-gated ion channel activity | GO | 214 |
| ligase activity\, forming aminoacyl-tRNA and related compounds | Tissue | 35 110 160 |
| ligase activity\, forming carbon-nitrogen bonds | Tissue | 278 |
| ligase activity\, forming phosphoric ester bonds | Tissue | 35 110 160 |
| lipase activity | GO | 401 |
| lipid catabolism | GO | 417 |
| lipoprotein binding | GO | 557 |
| lipoprotein biosynthesis | GO | 236 |
| Liver_1 | Tissue | 23 55 88 |
| Liver_2 | Tissue | 23 55 88 |
| Lung_1 | Tissue | 5 |
| Lung_2 | Tissue | 5 |
| Lymphoblastic_molt-4_1 | Tissue | 53 118 |
| Lymphoblastic_molt-4_2 | Tissue | 53 118 |
| Lymphoblastic_molt-4_3 | Tissue | 53 118 |
| lymphocyte activation | GO | 121 223 |
| lymphocyte antigen | GO | 501 |
| lymphocyte proliferation | GO | 521 |
| Lysine_degradation | KEGG | 305 |
| macromolecule catabolism | GO | 211 562 |
| magnesium ion binding | GO | 471 528 |
| main pathways of carbohydrate metabolism | GO | 306 |
| MAPKKK cascade | GO | 173 407 465 560 |
| MAPKKK cascade (osmolarity sensing) | GO | 407 465 560 |
| Matrix Metalloproteinases | GenMapp | 562 |
| membrane lipid catabolism | GO | 260 346 408 491 568 |
| membrane lipid metabolism | GO | 346 408 491 568 |
| mesoderm development | GO | 400 |
| metal ion binding | GO | 324 |
| metal ion homeostasis | GO | 191 262 |
| metal ion transporter activity | GO | 22 62 152 |
| metallocarboxypeptidase activity | GO | 231 402 492 568 |
| metalloendopeptidase activity | GO | 210 562 |
| metallopeptidase activity | GO | 210 562 |
| methyltransferase activity | GO | 349 |
| MHC class I receptor activity | GO | 144 293 345 436 |
| microtubule associated complex | GO | 438 533 |
| microtubule-based process | GO | 253 |
| microtubule cytoskeleton | GO | 438 533 |
| microtubule | GO | 395 509 |
| mitochondrial electron transport\, NADH to ubiquinone | Tissue | 25 77 152 |
| mitochondrial inner membrane | GO | 152 |
| mitochondrial membrane | GO | 62 152 |
| mitochondrion | GO | 152 |
| mitotic anaphase | GO | 397 |
| mitotic checkpoint | GO | 315 |
| Monoamine GPCRs | GenMapp | 372 441 |
| monocarboxylic acid transporter activity | GO | 0 71 186 341 411 511 |
| monocarboxylic acid transport | GO | 0 71 186 341 411 511 |
| monosaccharide binding | GO | 391 543 |
| monovalent inorganic cation transporter activity | GO | 62 152 |
| morphogenesis | GO | 220 |
| motor activity | GO | 196 253 |
| M phase | GO | 320 397 |
| M phase of mitotic cell cycle | GO | 320 397 |
| mRNA binding | GO | 183 |
| mRNA processing | GO | 332 |
| mRNA splicing | GO | 183 |
| muscle contraction | GO | 201 329 387 512 |
| muscle development | GO | 329 387 512 |
| muscle fiber | GO | 202 329 387 512 |
| Myelogenous_k-562_1 | Tissue | 17 52 118 |
| Myelogenous_k-562_2 | Tissue | 17 52 118 |
| NADH dehydrogenase activity | GO | 42 77 152 |
| NADH dehydrogenase (ubiquinone) activity | GO | 42 77 152 |
| negative regulation of cell proliferation | GO | 488 |
| neurotransmitter receptor activity | GO | 215 |
| neurotransmitter secretion | GO | 563 |
| Nicotinate_and_nicotinamide_metabolism | KEGG | 303 403 451 |
| nicotinic acetylcholine-activated cation-selective channel activity | GO | 216 267 328 415 |
| nicotinic acetylcholine-gated receptor-channel complex | GO | 216 267 328 415 |
| Nitrogen_metabolism | KEGG | 294 343 |
| nuclear chromatin | GO | 89 203 552 |
| nuclear chromosome | GO | 168 222 421 534 |
| nuclear division | GO | 320 397 |
| nuclear lamina | GO | 68 298 357 |
| nuclear membrane | GO | 298 357 |
| nuclear pore | GO | 352 |
| nuclease activity | GO | 32 83 114 151 |
| nucleic acid binding | GO | 32 83 114 151 |
| nucleobase metabolism | GO | 376 450 538 |
| nucleolar preribosome | GO | 525 |
| nucleolus | GO | 392 457 |
| nucleoside monophosphate biosynthesis | GO | 21 56 102 219 |
| nucleoside monophosphate phosphorylation | GO | 116 152 |
| nucleosome assembly | GO | 90 203 552 |
| nucleosome disassembly | GO | 90 203 552 |
| nucleotide binding | GO | 538 |
| nucleotide biosynthesis | GO | 102 219 |
| Nucleotide Metabolism | GenMapp | 337 397 |
| nucleotide metabolism | GO | 219 |
| nucleotide receptor activity | GO | 328 415 |
| nucleotidyltransferase activity | GO | 244 |
| nucleus | GO | 98 198 252 |
| Nutt03 10 | Clusters | 501 |
| Nutt03 14 | Clusters | 36 |
| Nutt03 15 | Clusters | 83 114 151 |
| Nutt03 16 | Clusters | 137 |
| Nutt03 18 | Clusters | 400 |
| Nutt03 23 | Clusters | 137 |
| Nutt03 26 | Clusters | 66 100 137 |
| Nutt03 36 | Clusters | 41 104 181 242 379 |
| Nutt03 38 | Clusters | 104 181 242 379 |
| Nutt03 41 | Clusters | 41 104 181 242 379 |
| Nutt03 43 | Clusters | 13 41 104 181 242 379 |
| Nutt03 44 | Clusters | 117 |
| organellar ribosome | GO | 377 |
| organic acid biosynthesis | GO | 327 462 |
| organic acid metabolism | GO | 40 |
| organic acid transporter activity | GO | 71 186 341 411 511 |
| organic acid transport | GO | 186 341 411 511 |
| organogenesis | GO | 220 |
| ossification | GO | 400 |
| Ovary_2 | Tissue | 1 |
| Ovary_3 | Tissue | 1 |
| oxidative phosphorylation | GO | 77 152 |
| Oxidative_phosphorylation | KEGG | 62 152 |
| oxidoreductase activity\, acting on CH-OH group of donors | Tissue | 286 |
| oxidoreductase activity\, acting on paired donors\, with incorporation or reduction of molecular oxygen\, 2-oxoglutarate as one donor\, and incorporation of one atom each of oxygen into both donors | Tissue | 423 478 |
| oxidoreductase activity\, acting on paired donors\, with incorporation or reduction of molecular oxygen | Tissue | 135 |
| oxidoreductase activity\, acting on paired donors\, with incorporation or reduction of molecular oxygen\, reduced flavin or flavoprotein as one donor\, and incorporation of one atom of oxygen | Tissue | 106 135 |
| oxidoreductase activity\, acting on single donors with incorporation of molecular oxygen | Tissue | 423 478 |
| oxidoreductase activity\, acting on the aldehyde or oxo group of donors\, NAD or NADP as acceptor | Tissue | 194 464 |
| oxidoreductase activity\, acting on the aldehyde or oxo group of donors | Tissue | 194 464 |
| oxidoreductase activity\, acting on the CH-CH group of donors\, other acceptors | Tissue | 294 343 |
| oxidoreductase activity\, acting on the CH-CH group of donors | Tissue | 184 221 |
| oxidoreductase activity\, acting on the CH-NH2 group of donors | Tissue | 373 |
| oxidoreductase activity\, acting on the CH-NH group of donors\, NAD or NADP as acceptor | Tissue | 224 272 377 |
| oxidoreductase activity\, acting on the CH-NH group of donors | Tissue | 224 272 377 |
| oxidoreductase activity\, acting on the CH-OH group of donors\, NAD or NADP as acceptor | Tissue | 286 |
| oxidoreductase activity | GO | 93 |
| oxygen and reactive oxygen species metabolism | GO | 132 310 |
| Pancreas_1 | Tissue | 55 88 |
| Pancreas_2 | Tissue | 55 88 |
| pancreatic ribonuclease activity | GO | 467 |
|